Searched for
CINNARIZINE
Dr Reddy's inks pact with Johnson & Johnson to acquire vertigo treatment brandDr. Reddy's Laboratories has finalized its acquisition of the Stugeron brand from Johnson & Johnson, encompassing EMEA regions, India, and ...- Dr Reddy’s shares slip nearly 2% on investor concerns amid $50 million foray into anti-vertigo categoryDr. Reddy's Laboratories' shares experienced a slight dip following the announcement of their acquisition of Stugeron from Johnson & Johnso...
- This time tailwinds for good and long term: 5 midcap pharma stocks where probably management has learnt the lessonPharma is one sector, where literally every company in the sector has gone through a phase where it is forced to have a look at its own bus...
- On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...
- Defensive Bets: 4 midcaps from pharma sector with ‘Buy’ & ‘Strong Buy’ ratings have upside potential of up to 31%As NIFTY gets even more volatile, there are some sectors which are traditionally considered defensive and they tend to get attention when m...
- Add FDC, target Rs 180: Centrum BrokingFDC is a smallcap company, operating in pharmaceuticals and health care sector.
Load More